Apolipoprotein E (Apo E) gene polymorphisms and recurrent pregnancy loss: a meta-analysis
1Guangxi Reproductive Medical Research Center, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, China.
Apolipoprotein E (Apo E) gene polymorphisms are linked to recurrent pregnancy loss (RPL). The Apo E4 allele increases RPL risk, while Apo E3 may be protective, and Apo E2 is a potential risk factor.
Area of Science:
- Genetics
- Reproductive Medicine
- Molecular Biology
Background:
- Recurrent pregnancy loss (RPL) is a complex condition with various potential contributing factors.
- Emerging research suggests a potential link between Apolipoprotein E (Apo E) gene polymorphisms and the risk of RPL.
Purpose of the Study:
- To investigate the association between Apolipoprotein E (Apo E) gene polymorphisms and recurrent pregnancy loss (RPL).
- To evaluate the risk and protective effects of different Apo E alleles in individuals experiencing RPL.
Main Methods:
- A meta-analysis was conducted, including 6 relevant studies.
- Association with RPL risk was estimated using dominant and recessive models.
- Odds Ratios (OR) and Relative Risks (RR) with 95% Confidence Intervals (CI) were calculated.
Main Results:
- The Apo E4 allele was associated with an increased risk of RPL (OR: 1.919, RR: 1.308).
- The Apo E3 polymorphism showed a protective effect against RPL (OR: 0.727, RR: 0.923).
- The Apo E2 polymorphism was identified as a potential risk factor for RPL (OR: 1.365).
Conclusions:
- A significant association exists between Apo E gene polymorphisms and recurrent pregnancy loss.
- Apo E4 acts as a risk factor, Apo E3 as a protective factor, and Apo E2 as a potential risk factor for RPL.
More Related Videos
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
Nondisjunction
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
